Live Quote · NASDAQMGXHealthcare· Biotechnology

Metagenomi, Inc. Common Stock

$1.26 4.13%(+$0.05)
TickerSpark Score
44/100
Weak
75
Valuation
20
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MGX research report →

52-Week Range5% of range
Low
$1.13
Current
$1.26
High
$3.95
Company Overviewwww.metagenomi.co

About the company

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States.

CEO
Jian Irish
IPO
2006
Employees
202
HQ
Emeryville, US

Price Chart

-21.74% · this period
$3.35$2.25$1.14Jul 02Dec 31Jul 02
Valuation
Market Cap
$47.44M
P/E
-0.55
P/S
2.12
P/B
0.34
EV/EBITDA
-0.76
Div Yield
0.00%
Profitability
Gross Margin
-12.54%
Op Margin
-415.48%
Net Margin
-384.61%
ROE
-51.23%
ROIC
-51.29%
Growth & Income
Revenue
$25.21M · -51.79%
Net Income
$-87,868,000 · -12.57%
EPS
$-2.36 · -12.92%
Op Income
$-96,013,000
FCF YoY
20.25%
Performance & Tape
52W High
$3.95
52W Low
$1.13
50D MA
$1.31
200D MA
$1.71
Beta
0.65
Avg Volume
170.35K

Get TickerSpark's AI analysis on MGX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 9, 26Reid Laurenceother17,400
Jun 9, 26Dere Willard Hother21,000
Jun 9, 26BJERKHOLT ERICother21,000
Jun 9, 26Eckhardt Juergenother21,000
Jun 5, 26Wapnick Pamelasell2,884
Jun 5, 26Irish Jiansell3,737
Jun 5, 26Wein Matthewsell558
Apr 1, 26Irish Jianother46,000
Apr 1, 26Irish Jianother276,000
Apr 1, 26Wein Matthewother11,000
Coverage · MGX

Our MGX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on MGX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate MGX report →
Internal Compare

Similar companies

Peers in the same neighborhood.